AUTOIMMUNITY, INFLAMMATION

Clinical trials for AUTOIMMUNITY, INFLAMMATION explained in plain language.

Never miss a new study

Get alerted when new AUTOIMMUNITY, INFLAMMATION trials appear

Sign up with your email to follow new studies for AUTOIMMUNITY, INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Safety check for ongoing autoimmune drug treatment

Disease control Recruiting now

This study monitors the long-term safety of secukinumab, a medication for autoimmune and inflammatory conditions. It's for people who have already been taking secukinumab in a previous Novartis study and need to continue treatment but can't get it through regular prescriptions. T…

Matched conditions: AUTOIMMUNITY, INFLAMMATION

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

AUTOIMMUNITY, INFLAMMATION

Get alerted when new AUTOIMMUNITY, INFLAMMATION trials appear

Safety check for ongoing autoimmune drug treatment